Recruiting and retaining nationally-recognized researchers and physicians to lead and develop UCRF initiatives is critical to the achievement of the fund’s strategic goals.

Hyman Muss, MD

Dr. Hyman Muss

Dr. Hyman Muss is creating a new program focusing on providing high-quality cancer care tailored to the needs of older adults. Read More


Dr. Kim Kasow

Dr. Kim Kasow directs the UNC Pediatric Bone Marrow Transplant Program. Read More


Dr. Derek Chiang

Derek Chiang first came to UNC-Chapel Hill as part of the highly-selective Morehead-Cain Scholars program and majored in Chemistry. Thanks to UCRF support, he returned to North Carolina to help advance the state’s cancer research agenda. Read More


Dr. Paul Armistead

Paul Armistead first came to UNC-Chapel Hill as part of the highly-selective Morehead-Cain Scholars program and majored in Chemistry. Thanks to UCRF support, he has returned to North Carolina to help advance the state’s cancer research agenda. Read More


Dr. Donald Rosenstein

Since Rosenstein joined the UNC School of Medicine, he has developed and now leads a psychooncology program that provides exceptional clinical services to patients and families facing cancer. Read More


Dr. William Zamboni

One of the first scientists recruited with help from the UCRF, Zamboni directs a drug development and clinical pharmacology lab focusing on the translational development of drugs, anticancer agents, and nanoparticles. Read More


Dr. Joseph DeSimone

DeSimone is a nationally recognized and highly acclaimed chemistry and materials science researcher, whose discoveries have led to more than 100 patents and the founding of several companies. Read More


Dr. Stephen Frye

Thanks to support from the UCRF, Frye was recruited in October 2007 to lead the Center for Integrative Chemical Biology and Drug Discovery (CICBDD) at UNC’s School of Pharmacy. Read More